Market capitalization | €930.45m |
Enterprise Value | €804.07m |
P/E (TTM) P/E ratio | 20.74 |
EV/Sales (TTM) EV/Sales | 0.52 |
P/S ratio (TTM) P/S ratio | 0.60 |
P/B ratio (TTM) P/B ratio | 0.73 |
Dividend yield | 1.08% |
Last dividend (FY22) | €0.15 |
Revenue growth (TTM) Revenue growth | 5.33% |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
1 Analyst has issued a forecast Rhön Klinikum:
1 Analyst has issued a forecast Rhön Klinikum:
Sep '24 |
+/-
%
|
||
Revenue | 1,546 1,546 |
5%
5%
|
|
Gross Profit | -71 -71 |
69%
69%
|
|
EBITDA | 107 107 |
7%
7%
|
EBIT (Operating Income) EBIT | 45 45 |
34%
34%
|
Net Profit | 45 45 |
41%
41%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Rhön-Klinikum AG engages in the provision of healthcare services. It operates hospitals and medical care centers that offers basic and standard, intermediate, maximum, and specialist care. Outpatient-inpatient basic and standard care is offered in portal clinics and medical care centers. The company was founded by Eugen Münch in 1973 and is headquartered in Bad Neustadt an der Saale, Germany.
Head office | Germany |
CEO | Tobias Kaltenbach |
Employees | 18,246 |
Founded | 1973 |
Website | www.rhoen-klinikum-ag.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.